Accumulation of aluminum (Al) in the brain is known to be a toxic insult that results in neurodegenerative diseases, and melatonin is known to have a neuroprotective role. The present study was designed to investigate the neuroprotective effects of melatonin for aluminum chloride (AlCl3)-induced neurotoxicity in rats. Twelve-week-old male Wistar rats were orally administered 175 mg/kg AlCl3 with or without 5 mg/kg melatonin intraperitoneal pretreatment. Group 3 intraperitoneally received 5 mg/kg melatonin, and group 4 rats were orally treated with saline solution for 8 weeks. A series of behavioral tests, biochemical analysis, and expression of Ad-associated proteins in the brain were determined after 7 weeks of all treatments. Our results indicated that AlCl3 treatment tends to induce memory and cognitive impairment. However, melatonin treatment attenuated amyloid beta (Aß) (1-42) level by decreasing ß-secretase, augmenting low-density lipoprotein receptor-related protein 1, and neprilysin protein expression. Moreover, AlCl3 induced endoplasmic reticulum (ER) stress and oxidative stress were attenuated by melatonin supplementation. In conclusion, these findings demonstrate a protective role of melatonin against Aß peptide accumulation, ER stress, and oxidative stress in the AlCl3 -treated AD model. Hence, the melatonin supplement might be an alternative way to alleviate the development of AD.